Hematology Special Issue (October) | CURE

Earlier Use of Novel Agents Promising for Older Patients with Hodgkin Lymphoma

October 14, 2016

Editor's Page

IN THIS SPECIAL ISSUE of CURE®, among other highlights in the treatment of blood cancers, we detail yet another example of a new application for immunotherapy, this time focusing on the use of PD-1 (checkpoint) immunotherapy to treat Hodgkin lymphoma.

Good News in Cancer? In Blood Diseases, There Are Positive Developments to Share

October 13, 2016

From the Chairman

IT’S NOT OFTEN that we hear the terms “good news” and“cancer” in the same sentence. But this special issue of CURE® does bring good news — reports of a series of exciting breakthroughs in the blood cancer arena that are significantly improving treatment options for patients.